نتایج جستجو برای: trivalent vaccine

تعداد نتایج: 111876  

Journal: :The New England journal of medicine 2008
Helen E Jenkins R Bruce Aylward Alex Gasasira Christl A Donnelly Emmanuel A Abanida Titi Koleosho-Adelekan Nicholas C Grassly

BACKGROUND The number of cases of paralytic poliomyelitis has declined in Nigeria since the introduction of newly licensed monovalent oral poliovirus vaccines and new techniques of vaccine delivery. Understanding the relative contribution of these vaccines and the improved coverage to the decline in incident cases is essential for future planning. METHODS We estimated the field efficacies of ...

Journal: :Dalton transactions 2012
Josef Hamacek Céline Besnard Nathalie Mehanna Jérôme Lacour

A new tripodal ligand has been designed by coupling pyridyldicarbonyl binding strands with a triazatriangulenium platform (TATA). The complexation reaction with europium provides a C(3)-symmetrical mononuclear compound that is characterized with NMR, ESMS and qualitatively with single-crystal X-ray crystallography. In addition, photophysical studies of this dual emissive system have been perfor...

2016
Daryl G.S. Smith Geneviève Gingras Yves Aubin Terry D. Cyr

Herein we present the data necessary for generation of alternative means to produce equimolar mixtures of peptides ("Design and Expression of a QconCAT Protein to Validate Hi3 Protein Quantification of Influenza Vaccine Antigens" (D.G.S. Smith, G. Gingras, Y. Aubin, T.D. Cyr, 2016) [1]), such as QConCAT ("Trends in QconCATs for targeted proteomics" (J. Chen, I.V. Turko, 2014) [2] , "Natural fla...

Journal: :Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 2011
C Savulescu S Jiménez-Jorge S de Mateo J Ledesma F Pozo I Casas A Larrauri

We present preliminary results of a case-control study to estimate influenza vaccine effectiveness in Spain, from week 50 of 2010 to week 6 of 2011. The adjusted effectiveness of the vaccine in preventing laboratory-confirmed influenza due to any type of influenza virus was 50% (95% CI: -6 to 77%) for the trivalent seasonal vaccine and 72% (95% CI: 7 to 92%) for both trivalent seasonal and mono...

2017
Zeinab Mohamed Ali Mervat Abd El Monaem Hassan Hussein Ali Hussein Basem Mohamed Ahmed Ahmed Abd El-Ghany El Sanousi

Aim The objective of the present study was to prepare a trivalent inactivated vaccine of Newcastle disease virus (NDV), H5N1, and H9N2 viruses. Materials and Methods Three monovalent and a trivalent vaccines were prepared by emulsifying inactivated NDV (LaSota strain), reassortant H5N1, and H9N2 viruses with Montanide ISA 71 oil adjuvant. Parameters used for evaluation of the efficacy of the ...

Journal: :The Medical journal of Australia 2010
Michael S Gold Paul Effler Heath Kelly Peter C Richmond Jim P Buttery

Journal: :The British journal of general practice : the journal of the Royal College of General Practitioners 2011
David Mant Richard Mayon-White

Journal: :Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 2010
D Carcione C Giele L S Goggin K S Kwan D W Smith G K Dowse D B Mak P Effler

We conducted a prospective household transmission study to examine whether receipt of 2009 trivalent influenza vaccine (TIV) was associated with increased risk of influenza-like illness (ILI) among contacts of confirmed pandemic influenza A(H1N1) 2009 patients. In the week following onset of pandemic illness in a household member, 46 (15%) of 304 TIV-vaccinated contacts, and 174 (15%) of 1,162 ...

Journal: :Pediatrics 2016

The purpose of this statement is to update recommendations for the routine use of seasonal influenza vaccine and antiviral medications for the prevention and treatment of influenza in children. The AAP recommends annual seasonal influenza immunization for everyone 6 months and older, including children and adolescents. Highlights for the upcoming 2016-2017 season include the following: 1. Annua...

Journal: :Health technology assessment 2011
P de Whalley W Walker M D Snape C Oeser M Casey P Moulsdale C Harrill N Andrews K Hoschler B Thompson C Jones J Chalk S Kerridge R Tomlinson P T Heath A Finn S Faust E Miller A J Pollard

INTRODUCTION Pandemic influenza A H1N1 infections occurred worldwide from 2009. Children were particularly vulnerable. Novel vaccines were used during the pandemic. OBJECTIVE To assess the persistence of antibody to H1N1 influenza 1 year after children aged 6 months to 12 years had been immunised with two doses of either a non-adjuvanted whole-virion H1N1 influenza vaccine or an AS03B-adjuvan...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید